IP Verse

Mylan Pharmaceuticals Inc. vs Cosmo Technologies Limited et al.

The detailed information for PTAB case with proceeding number IPR2017-01035 filed by Mylan Pharmaceuticals Inc. against Cosmo Technologies Limited et al. on Mar 9, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2017-01035
Filing Date: Mar 9, 2017
Petitioner: Mylan Pharmaceuticals Inc.
Respondent: Cosmo Technologies Limited et al.
Status: Terminated-Settled
Respondent Application Number: 14308279
Respondent Tech Center: 1600
Respondent Patent Number: 9320716
Institution Decision Date: Sep 21, 2017
Termination Date: Jan 17, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Termination Decision Document	Jan 17, 2018	PAPER	BOARD
Notice of Joint Stipulation to Modify Due Dates 1 and 2	Dec 1, 2017	PAPER	PATENT OWNER
Joint Motion to Terminate Proceedings	Nov 15, 2017	PAPER	PATENT OWNER
Joint Request to Treat Agreement as Business Confidential	Nov 15, 2017	PAPER	PATENT OWNER
Ex 2037 Settlement and License Agreement	Nov 15, 2017	EXHIBIT	PATENT OWNER
Ex 2025 Trial transcript 2017-05-23	Oct 10, 2017	EXHIBIT	PATENT OWNER
Patent Owner's Preliminary Response (redacted per Paper 19)	Oct 10, 2017	PAPER	PATENT OWNER
Patent Owner's Objections to Exhibits	Oct 5, 2017	PAPER	PATENT OWNER
Petitioner's Evidentiary Objections	Oct 5, 2017	PAPER	PETITIONER
Decision Motions to Seal	Sep 25, 2017	PAPER	BOARD
Trial Instituted Document	Sep 21, 2017	PAPER	BOARD
Scheduling Order	Sep 21, 2017	PAPER	BOARD
Petitioner's Response to Motion to Seal	Jul 24, 2017	PAPER	PETITIONER
Patent Owner's Exhibit List	Jul 20, 2017	PAPER	PATENT OWNER
Patent Owner's Response to Motion to Seal	Jul 20, 2017	PAPER	PATENT OWNER
Patent Owner's Response to Motion to Expunge	Jul 20, 2017	PAPER	PATENT OWNER
Ex 2036 Redacted email chain	Jul 20, 2017	EXHIBIT	PATENT OWNER
Motion to Seal	Jul 13, 2017	PAPER	PETITIONER
Motion to Expunge	Jul 13, 2017	PAPER	PETITIONER
Patent Owner Preliminary Response (unredacted)	Jun 22, 2017	PAPER	PATENT OWNER
Patent Owner Preliminary Response (redacted)	Jun 22, 2017	PAPER	PATENT OWNER
Motion to Seal	Jun 22, 2017	PAPER	PATENT OWNER
Patent Owner's Exhibit List	Jun 22, 2017	PAPER	PATENT OWNER
Ex 2001 Brunner 2006	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2002 Wilding 2000	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2003 Redacted Letter 2017-06-07	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2004 Hamedani 1997	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2007 Sandborn 2012 Core I	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2009 Lofberg 1998	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2012 Amendment and Response to Advisory Action	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2017 Greenstein 1985	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2018 Aulton 1988	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2020 Ansel Pharmaceutical Dosage Forms	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2005 Koutroubakis	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2006 Sandborn 2007	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2008 Kenyon 1997	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2010 Lofberg 1993 Oral formulation	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2011 Amendment and Response	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2013 AF Response 2016-02-17	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2014 Merriam-Webster Collegiate Dictionary	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2015 McGraw-Hill	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2016 US Patent No. 8,293,273	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2019 Staniforth 1985	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2023 Shi 2015	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2026	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2027 Corren 1999	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2028 Friend 1998	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2029 HPE 1997	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2031 Stevens 2013	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2035 Yamada	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2021 Crooks 1976	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2022 Hersey 1975	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2024 Roy US Patent No. 3,974,249 (1976)	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2025 Trial Transcript 2017-05-23	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2030 Nicholls 2013	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2032 Hebden 1999	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2033 WO9216206A1	Jun 22, 2017	EXHIBIT	PATENT OWNER
Ex 2034 National Library of Medicine Colon	Jun 22, 2017	EXHIBIT	PATENT OWNER
Power of Attorney	Mar 30, 2017	PAPER	PATENT OWNER
Mandatory Notice	Mar 30, 2017	PAPER	PATENT OWNER
Notice of Accord Filing Date	Mar 22, 2017	PAPER	BOARD
Petition for Inter Partes Review	Mar 9, 2017	PAPER	PETITIONER
Petitioner's Power of Attorney	Mar 9, 2017	PAPER	PETITIONER
Mylan Ex 1001 U.S. Patent No. 9,320,716	Mar 9, 2017	EXHIBIT	PETITIONER
Petitioner's Exhibit List	Mar 9, 2017	PAPER	PETITIONER
MYLAN Ex 1002 U.S. Patent No. 8,784,888	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1006 Declaration of Anthony Palmieri III, Ph.D., R.Ph.	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1007 CV of Anthony Palmieri, Ph.D., R.Ph.	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1009 U.S. Patent No. 5,811,388	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1011 U.S. Patent Appl. Pub. No. 2006/0134208	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1012 Markman Opinion and Order	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1008 U.S. Patent No. 5,681,584	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1010 U.S. Patent No. 6,239,120	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1013 Amendment and Response to Advisory Action	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1014 Substitute Specification	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1016 Amendment and Response to Office Action	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1017 U.S. Patent No. 6,607,751	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1018 Campieri et al.,	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1022 PCT International Publication No. WO 96/36318	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1023 U.S. Patent No. 5,342,625	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1024 PCT International Publication No. WO 99/39700,	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1025 FDA Inactive Ingredient Guide	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1026 Handbook of Pharmaceutical Excipients	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1028 Remington: The Science and Practice of Pharmacy, Vol. 1 (1995)	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1030 Hawley¿¿¿s Condensed Chemical Dictionary	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1032 Entocort¿¿ EC Highlights of Prescribing Information	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1015 Amendment After Final	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1035 Flanders et al.,	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1036 Gandhi et al.,	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1038 Daly et al.,	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1039 S.S. Davis, S.T.P. Pharma (1987)	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1042 U.S. Provisional Application No. 60/080,274	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1044 See A Blume, B Arnold, HU Weltzien	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1033 Svensson et al.	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1034 U.S. Patent No. 6,395,300	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1037 US Patent No. 4,880,830	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1040 U.S. Patent No. 5,849,327	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1041 U.S. Patent No. 5,643,602	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1043 Gliko-Kabir et al.,	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1045 Qiu et al.,	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1046 M. Efentakis et al.,	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1047 Uceris¿¿ website, https://www.uceris.com/tablet/	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1048 Santarus¿¿¿ CEO Discusses FDA Approval Of UCERIS	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1049 Uceris¿¿ Instant Savings Program	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1050 Transcript of the Second Quarter 2014 Earnings Conf Call	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1051 L.W. Doner,	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1052 Amendment filed on January 15, 2013 in U.S. Patent Appl. No. 13/617,138	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1053 Specification of U.S. Patent Application No. 10/009,532	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1054 Specification of 12/210,969 application	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1060 Orange Book Listing of Uceris¿¿	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1061 Hawley¿¿¿s Condensed Chemical Dictionary	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1062 N. Robinson, of Pharmacy and Pharmacology	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1055 Specification of 13/249,839 application	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1056 Specification of 13/462,409 application	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1057 Final Office Action of March 6, 2013 in U.S. Patent Appl. No. 13/617,138	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1058 Applicant-Initiated Interview Summary of April 23, 2013	Mar 9, 2017	EXHIBIT	PETITIONER
MYLAN Ex 1059 Original Specification as field on September 14, 2012	Mar 9, 2017	EXHIBIT	PETITIONER